Literature DB >> 10703681

Time dependency of factors affecting renal allograft survival.

Surazee Prommool1, Gian S Jhangri2, Sandra M Cockfield1, Philip F Halloran1.   

Abstract

The function of renal transplants can deteriorate at any time posttransplant, but the risks and mechanisms may differ at different times posttransplant. Survival of 522 consecutive cadaveric renal transplant recipients followed for at least 6 mo were analyzed, with patient death censored. The overall risk factors in univariate analysis were acute rejection requiring antibody therapy (AR), delayed graft function, elevated serum creatinine at 6 mo, high panel-reactive antibodies, and donor age > or =55 yr, with borderline effects of recipient age and female gender. These risks were studied in each of three intervals posttransplantation: < or =6 mo, 6 mo to 5 yr, and >5 yr. Of the 135 graft failures, 53 occurred < or =6 mo, 61 between 6 mo and 5 yr, and 21 beyond 5 yr. By multivariate analysis. the risks for graft failure in interval < or =6 mo were AR (hazard ratio (HR) = 4.86, P < 0.001); delayed graft function (HR = 1.47, P = 0.06): and high panel-reactive antibodies (HR = 2.04, P = 0.0(3). Between 6 mo and 5 yr, the risks for graft loss were AR (HR = 2.87, P < 0.001) and serum creatinine at 6 mo > or =150 micromol/L (HR = 3.69, P < 0.001). Beyond 5 yr the risk factors were donor age > or =55 yr (HR = 5.87, P = 0.002), with a borderline effect of kidneys from female donors (HR = 2.28, P = 0.07). HLA-A, -B, and -DR matching and presensitization had most of their effect through early AR and impaired function. The results indicate that risks for graft loss are time-dependent: early losses correlate with injury and rejection, but late events correlate with donor age and possibly workload.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10703681     DOI: 10.1681/ASN.V113565

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  19 in total

1.  On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes.

Authors:  Yingyos Avihingsanon; Naili Ma; Martha Pavlakis; W James Chon; Marc E Uknis; Anthony P Monaco; Christiane Ferran; Isaac Stillman; Asher D Schachter; Christina Mottley; Xin Xiao Zheng; Terry B Strom
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

2.  Center-level variation in the development of delayed graft function after deceased donor kidney transplantation.

Authors:  Babak J Orandi; Nathan T James; Erin C Hall; Kyle J Van Arendonk; Jacqueline M Garonzik-Wang; Natasha Gupta; Robert A Montgomery; Niraj M Desai; Dorry L Segev
Journal:  Transplantation       Date:  2015-05       Impact factor: 4.939

Review 3.  The impact of age on rejection in kidney transplantation.

Authors:  Johan W de Fijter
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  An economic model of 2-hour post-dose ciclosporin monitoring in renal transplantation.

Authors:  Paul A Keown; Bryce Kiberd; Robert Balshaw; Shideh Khorasheh; Carlo Marra; Philip Belitsky; Zoltan Kalo
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 5.  Immunosuppression for long-term maintenance of renal allograft function.

Authors:  Gerd Offermann
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  [Current problems of kidney transplantation].

Authors:  H Haller; N Richter; V Bröcker; W Gwinner; F Gueler; A Schwarz
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

7.  Study of the effect of donor source on graft and patient survival in pediatric renal transplant recipients.

Authors:  Osama Gheith; Alaa Sabry; Sherief Abd El-Baset; Nabil Hassan; Hussein Sheashaa; Sameh Bahgat; El-Metwally El-Shahawy
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

Review 8.  Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.

Authors:  Roberto Marcén
Journal:  Drugs       Date:  2009-11-12       Impact factor: 9.546

9.  Kidney NGAL is a novel early marker of acute injury following transplantation.

Authors:  Jaya Mishra; Qing Ma; Caitlin Kelly; Mark Mitsnefes; Kiyoshi Mori; Jonathan Barasch; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2006-04-14       Impact factor: 3.714

10.  Marginal kidney donor.

Authors:  Ganesh Gopalakrishnan; Siva Prasad Gourabathini
Journal:  Indian J Urol       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.